SCHEMBL16115221

SCHEMBL16115221

Cc1c(-c2ccncc2)c[nH]c1C(=O)O

nearest known ligand 0.74

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCNC P24863 8/20 0.74
CDK8 P49336 8/20 0.74
IMPDH2 P12268 4/20 0.42
CSNK1A1 P48729 1/20 0.41
CSNK1D P48730 1/20 0.41
CLK2 P49760 1/20 0.41
CSNK1G1 Q9HCP0 1/20 0.41
DYRK1A Q13627 2/20 0.41
PARP10 Q53GL7 1/20 0.41
PARP11 Q9NR21 1/20 0.41
GPR35 Q9HC97 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NFATC1 O95644 1/20 0.40
GSK3B P49841 1/20 0.40
NAPRT Q6XQN6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16116177 0.85 CCNC (0.55) CCNCCDK8GPR35
SCHEMBL16116379 0.85 CCNC (1.00) CCNCCDK8IMPDH2CSNK1A1CSNK1D
SCHEMBL31189709 0.83 CCNC (0.68) CCNCCDK8IMPDH2CSNK1A1CSNK1D
SCHEMBL16115235 0.81 CCNC (0.77) CCNCCDK8DYRK1ANFATC1GSK3B
SCHEMBL16115990 0.80 CCNC (0.65) CCNCCDK8IMPDH2MAPK1HSD17B10
SCHEMBL16116227 0.80 CCNC (0.77) CCNCCDK8IMPDH2DYRK1AMAPK1
SCHEMBL16115256 0.80 CCNC (0.76) CCNCCDK8IMPDH2DYRK1AMAPK1
SCHEMBL26113876 0.79 CCNC (0.63) CCNCCDK8IMPDH2CSNK1A1CSNK1D
SCHEMBL16116161 0.77 CCNC (0.57) CCNCCDK8DYRK1AGPR35NFATC1
SCHEMBL16116231 0.76 CCNC (0.76) CCNCCDK8IMPDH2DYRK1AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014154723-A1 NOVEL PYRROLE DERIVATIVES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2014-10-02 WO disclosed
WO-2014154723-A1 NOVEL PYRROLE DERIVATIVES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2014-10-02 WO disclosed